Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
CC transcript
MARIMED INC. (WORX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/04/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
Docs: "MariMed Reports Second Quarter 2023 Earnings"
06/12/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/08/2023 8-K Quarterly results
Docs: "MariMed Reports First Quarter 2023 Earnings"
04/27/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/17/2023 8-K Quarterly results
03/07/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/06/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
03/06/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "EX-3.2(A)"
03/01/2023 8-K Quarterly results
Docs: "MariMed Reports Fourth Quarter and Full Year 2022 Financial Results"
01/24/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "[FORM OF] COMMON STOCK PURCHASE WARRANT MARIMED INC.",
"[FORM OF] PROMISSORY NOTE",
"LOAN AND SECURITY AGREEMENT",
"MariMed Closes $35 Million Credit Facility to Accelerate its Strategic Growth Plans"
12/14/2022 8-K Quarterly results
12/12/2022 8-K Quarterly results
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/07/2022 8-K Quarterly results
10/31/2022 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
09/22/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
09/07/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Form of Third Amendment to Employment Agreement, effective as of September 7, 2022, between MariMed Inc. and Jon R. Levine",
"MariMed Appoints Jon Levine as President"
08/09/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/08/2022 8-K Quarterly results
05/18/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
05/10/2022 10-Q Quarterly Report for the period ended March 31, 2022
04/14/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "MariMed Receives Maryland State Approval for Transfer of Ownership of Kind Therapeutics USA"
03/21/2022 8-K Conference call transcript
Docs: "MariMed Inc. Fourth Quarter 2021 Financial Results Conference Call March 17, 2022 — 8:00 a.m. E.T. Length: 45 minutes Corporate participants Steve West"
03/16/2022 10-K Annual Report for the period ended December 31, 2021
01/05/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "MariMed Announces Agreement to Acquire Kind Therapeutics USA, LLC, A Maryland Licensed Vertically Integrated Cannabis Business"
11/18/2021 8-K Conference call transcript
09/28/2021 8-K Quarterly results
08/19/2021 8-K Quarterly results
08/17/2021 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/16/2021 10-Q Quarterly Report for the period ended June 30, 2021
07/23/2021 PRE 14A Form PRE 14A - Other preliminary proxy statements:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy